NASDAQ:AFJK · NASDAQ Global Market
-$3.66 today
Vol 0.04M · Avg 0.02M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Aimei Health Technology Co., Ltd earnings power becomes long-term shareholder value. Use this page to compare AFJK returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
13.2%
avg 5.7%
ROIC
-7.8%
avg -3.1%
ROA
8.8%
avg 4.2%
Analysis
ROE is currently the strongest return metric at 13.2% versus its period average of 5.7%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Junheng Xie | Chief Executive Officer, Secretary & Director | — | — | 37 | — | — |
Heung Ming Wong | Chief Financial Officer & Director | — | — | 56 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | N/A | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
CSLM Digital Asset Acquisition Corp III Class A Ordinary Shares
NASDAQ:KOYN
$242.26M
Eureka Acquisition Corp Class A Ordinary Share
NASDAQ:EURK
$87.24M
UY Scuti Acquisition Corp.
NASDAQ:UYSC
$82.02M
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
$79.10M
Origin Investment Corp I Units
NASDAQ:ORIQU
$69.02M
Bayview Acquisition Corp Class A Ordinary Shares
NASDAQ:BAYA
$65.30M
Ribbon Acquisition Corp
NASDAQ:RIBB
$54.15M
Who manages AFJK?
Aimei Health Technology Co., Ltd (AFJK) lists 2 active executives. The top listed executive is Junheng Xie, Chief Executive Officer, Secretary & Director.
Are AFJK insiders buying or selling?
Recent insider activity shows net selling of $1.63M.
Explore More
Continue the stock analysis
Jump to another research area for this company.